SRT Sartorius AG

At today’s Annual Shareholders’ Meeting in Goettingen, Germany, shareholders approved all board proposals by a large majority. Thus, the Annual Shareholders' Meeting passed the resolution to pay dividends of 0.82 euro per preference share (previous year: 0.62 euro) and 0.80 euro per ordinary share (previous year: 0.60 euro). Accordingly, the total amount of dividends to be paid out will rise 32.8% to 13.8 million euros from a year earlier.

During the regular election of share owner representatives to the Supervisory Board, shareholders re-elected Prof. Dr. Dres. h.c. Arnold Picot, Dr. Dirk Basting, Dr. Lothar Kappich and Prof. Dr. Gerd Krieger. Prof. Dr. Klaus Rüdiger Trützschler and Prof. Dr. Thomas Scheper, were elected for the first time. Prof. Dr. Trützschler has been a member of the Supervisory Board since November 2011. He had been appointed by court order after the death of Supervisory Board member Dr. Michael Schulenburg. Prof. Dr. Thomas Scheper was proposed for election because Prof. Dr. rer. nat. Dr.-Ing. E.h. Heribert Offermanns, who had been a member of the Sartorius Supervisory Board since 2000, was no longer available to serve for a further term on the grounds of age. The new Supervisory Board will serve for a term of five years.

Furthermore, the Annual Shareholders’ Meeting granted discharge to the Supervisory Board and to the Executive Board by a considerable majority. Some 300 share owners representing nearly 60% of the voting share capital attended this year’s Annual Shareholders’ Meeting.

This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties.

This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

Presentation Held by CEO Dr. J. Kreuzburg at the 2012 Annual Shareholders’ Meeting

You will find a presentation held by Dr. Joachim Kreuzburg at the 2012 Annual Shareholders’ Meeting and further information at:

www.sartorius.com/de/konzern/investor-relations/sartorius-ag/hauptversammlung/2012

Current Image Files

Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG:www.sartorius.com/fileadmin/media/global/company/pr_20120419_kreuzburg.jpg

Sartorius products used in the manufacture of medications:www.sartorius.com/fileadmin/media/global/company/pr_20120419_bioprocess_solutions.jpg

Sartorius products used in laboratory research:www.sartorius.com/fileadmin/media/global/company/pr_20120419_lab_products_services.jpg

Upcoming Financial Dates

April 24, 2012 Publication of first-quarter figures (Jan. – March 2012)

May 21 | 22, 2012 Cheuvreux Pan-Europe Forum in London, UK

July 25, 2012 Publication of first-half figures (Jan. – June 2012)

A Profile of Sartorius

The Sartorius Group is a leading international laboratory and process technology provider covering the segments of Bioprocess Solutions, Lab Products & Services and Industrial Weighing. In 2011, the technology group earned sales revenue of 733.1 million euros. Founded in 1870, the Goettingen-based company currently employs more than 5,000 persons. The major areas of activity of its Bioprocess Solutions segment cover filtration, fluid management, fermentation, cell cultivation and purification, and focus on production processes in the biopharmaceutical industry. The Lab Products & Services segment primarily manufactures laboratory instruments and consumables. Industrial Weighing concentrates on weighing, monitoring and control applications in the manufacturing processes of the food, chemical and pharma sectors. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.

Sartorius (TG:SRT)
Historical Stock Chart
From Apr 2024 to May 2024

Sartorius (TG:SRT)
Historical Stock Chart
From May 2023 to May 2024